IGF2BP1 plays a dominant role as an m6A reader and is involved in a variety of cancer processes, such as leukemia (43), endometrial cancer (EC) (44), BCA (45), lung adenocarcinoma (LUAD) (46), and glioblastoma (GBM) (47). The gene discussed is IGF2BP1; the disease is glioblastoma.